Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.64B |
| 2 |
Tesla
TSLA
|
+$632M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$587M |
| 4 |
iShares MSCI Taiwan ETF
EWT
|
+$468M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$1.01B |
| 2 |
NVIDIA
NVDA
|
+$752M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$474M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.35% |
| 2 | Technology | 1.76% |
| 3 | Financials | 1% |
| 4 | Communication Services | 0.83% |
| 5 | Healthcare | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
FuelCell Energy
FCEL
$1.63B
| $5.7M | ﹤0.01% |
28,413
+27,253
| +2,349% | +$5.41M |
|
2527
CALL
Tapestry
TPR
$32.8B
| $5.7M | ﹤0.01% |
154,000
+33,500
| +28% | +$1.38M |
|
2528
PUT
Ball Corp
BALL
$16.8B
| $5.69M | ﹤0.01% |
63,200
+12,500
| +25% | +$1.11M |
|
2529
PUT
BioMarin Pharmaceuticals
BMRN
$12.4B
| $5.68M | ﹤0.01% |
73,500
-29,100
| -28% | -$2.3M |
|
2530
CALL
10x Genomics
TXG
$6.61B
| $5.68M | ﹤0.01% |
39,000
-32,700
| -46% | -$5.61M |
|
2531
CALL
AGNC Investment
AGNC
$12.9B
| $5.67M | ﹤0.01% |
359,700
-380,900
| -51% | -$6.17M |
|
2532
CALL
Matador Resources
MTDR
$6.09B
| $5.67M | ﹤0.01% |
149,100
+55,600
| +59% | +$1.71M |
|
|
VSTO
2533
CALL
DELISTED
Vista Outdoor Inc.
VSTO
| $5.67M | ﹤0.01% |
140,700
-130,700
| -48% | -$5.38M |
|
|
CERN
2534
PUT
DELISTED
Cerner Corp
CERN
| $5.67M | ﹤0.01% |
80,400
+29,200
| +57% | +$2.26M |
|
2535
CALL
Northern Oil and Gas
NOG
$2.35B
| $5.67M | ﹤0.01% |
264,800
+8,700
| +3% | +$152K |
|
|
SPYM
2536
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
| $5.67M | ﹤0.01% |
112,301
+104,834
| +1,404% | +$5.44M |
|
2537
PUT
Scorpio Tankers
STNG
$3.81B
| $5.66M | ﹤0.01% |
305,400
+165,200
| +118% | +$2.76M |
|
2538
PUT
Darling Ingredients
DAR
$9.44B
| $5.66M | ﹤0.01% |
78,700
-9,000
| -10% | -$644K |
|
|
TTM
2539
CALL
DELISTED
Tata Motors Limited
TTM
| $5.66M | ﹤0.01% |
252,000
+59,800
| +31% | +$1.22M |
|
2540
CALL
iQIYI
IQ
$1.28B
| $5.66M | ﹤0.01% |
704,500
-918,300
| -57% | -$9.52M |
|
2541
CALL
Ligand Pharmaceuticals
LGND
$6.36B
| $5.66M | ﹤0.01% |
65,082
-19,076
| -23% | -$1.48M |
|
2542
CALL
Invesco
IVZ
$13.9B
| $5.65M | ﹤0.01% |
234,300
-67,500
| -22% | -$1.69M |
|
2543
PUT
Capri Holdings
CPRI
$1.74B
| $5.64M | ﹤0.01% |
116,500
-18,900
| -14% | -$1.03M |
|
2544
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $5.64M | ﹤0.01% |
+215,013
| New | +$5.67M |
|
2545
PUT
Qfin Holdings
QFIN
$1.61B
| $5.64M | ﹤0.01% |
277,400
+116,400
| +72% | +$2.75M |
|
|
CTXS
2546
CALL
DELISTED
Citrix Systems Inc
CTXS
| $5.64M | ﹤0.01% |
52,500
+13,600
| +35% | +$1.47M |
|
|
SCOA
2547
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $5.62M | ﹤0.01% |
577,644
+13,397
| +2% | +$130K |
|
2548
CALL
Newell Brands
NWL
$2.56B
| $5.62M | ﹤0.01% |
253,700
+136,400
| +116% | +$3.48M |
|
2549
PUT
Fulgent Genetics
FLGT
$527M
| $5.61M | ﹤0.01% |
62,400
-89,200
| -59% | -$8.11M |
|
2550
PUT
GSK
GSK
$106B
| $5.61M | ﹤0.01% |
117,520
-110,000
| -48% | -$5.53M |
|
Similar funds
Jane Street's Q3 2021 Portfolio in Review
As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.
- Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
- Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
- Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
- Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
- Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
- Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.
Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.